Goldmann, 1996, Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership, JAMA, 275, 234, 10.1001/jama.1996.03530270074035
Interagency Task Force on Antimicrobial Resistance, 2001, 1
European Centre for Disease Prevention and Control (ECDC), 2012
Meyer, 2013, Antibiotic consumption and resistance: data from Europe and Germany, Int J Med Microbiol, 303, 388, 10.1016/j.ijmm.2013.04.004
Dancer, 2013, Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum beta-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus, Int J Antimicrob Agents, 41, 137, 10.1016/j.ijantimicag.2012.10.013
Fournier, 2012, Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE), Antimicrob Resist Infect Control, 1, 9, 10.1186/2047-2994-1-9
Grau, 2013, How to measure and monitor antimicrobial consumption and resistance, Enferm Infecc Microbiol Clin, 31, 16, 10.1016/S0213-005X(13)70128-9
Dumartin, 2010, Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007, J Antimicrob Chemother, 65, 2028, 10.1093/jac/dkq228
Filius, 2005, An additional measure for quantifying antibiotic use in hospitals, J Antimicrob Chemother, 55, 805, 10.1093/jac/dki093
Kuster, 2008, Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting, Infection, 36, 549, 10.1007/s15010-008-7462-z
Muller-Pebody, 2004, Increase and change in pattern of hospital antimicrobial use, Denmark, 1997–2001, J Antimicrob Chemother, 54, 1122, 10.1093/jac/dkh494
Ronning, 2003, Problems in collecting comparable national drug use data in Europe: the example of antibacterials, Eur J Clin Pharmacol, 58, 843, 10.1007/s00228-003-0572-8
Dellit, 2007, Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship, Clin Infect Dis, 44, 159, 10.1086/510393
Ruiz, 2018, Antimicrobial stewardship programme in critical care medicine: a prospective interventional study, Med Intensiva, 42, 266, 10.1016/j.medin.2017.07.002
World Health Organization, 2016
Polk, 2007, Measurement of adult antibacterial drug use in 130 US Hospitals: comparison of defined daily dose and days of therapy, Clin Infect Dis, 44, 664, 10.1086/511640
Mandy, 2004, Methodological validation of monitoring indicators of antibiotics use in hospitals, Pharm World Sci, 26, 90, 10.1023/B:PHAR.0000018595.78732.1c
de With, 2004, Antibiotic use in German university hospitals 1998–2000 (Project INTERUNI-II), Int J Antimicrob Agents, 24, 213, 10.1016/j.ijantimicag.2004.03.015
Kern, 2005, The MABUSE-INTERREGIO-II project team: antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001–2002, Infection, 33, 333, 10.1007/s15010-005-5059-3
Tsai, 2015, Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill, Curr Opin Crit Care, 21, 412, 10.1097/MCC.0000000000000229
Zagorski, 2002, The effect of renal dysfunction on antimicrobial use measurements, Clin Infect Dis, 35, 1491, 10.1086/344753
Kern, 2005, Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999–2002, J Antimicrob Chemother, 55, 57, 10.1093/jac/dkh510
Muller, 2006, Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital, Br J Clin Pharmacol, 61, 585, 10.1111/j.1365-2125.2006.02605.x
Knaus, 1985, APACHE II: a severity of disease classification system, Crit Care Med, 13, 818, 10.1097/00003246-198510000-00009
Monnet, 2007, Measuring antimicrobial use: the way forward, Clin Infect Dis, 44, 671, 10.1086/511649
Barlam, 2016, Implementing an Antibiotic Stewardship Program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America, Clin Infect Dis, 62, 1197, 10.1093/cid/ciw217
Kubin, 2012, Lack of significant variability among different methods for calculating antimicrobial days of therapy, Infect Control Hosp Epidemiol, 33, 421, 10.1086/664770